SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-082416
Filing Date
2022-07-25
Accepted
2022-07-25 16:26:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2221746d1_424b5.htm 424B5 427066
2 GRAPHIC tm2221746d1_424b5img001.jpg GRAPHIC 36011
3 GRAPHIC tm2221746d1_424b5img004.jpg GRAPHIC 9258
  Complete submission text file 0001104659-22-082416.txt   490807
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-265956 | Film No.: 221103664
SIC: 2834 Pharmaceutical Preparations